Credit Suisse’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.39M Sell
115,425
-4,018
-3% -$59.8K ﹤0.01% 2078
2023
Q4
$2.01M Buy
119,443
+1,510
+1% +$21.4K ﹤0.01% 1880
2023
Q3
$1.77M Sell
117,933
-7,069
-6% -$119K ﹤0.01% 1901
2023
Q2
$2.36M Buy
125,002
+19,281
+18% +$306K ﹤0.01% 1803
2023
Q1
$1.89M Buy
105,721
+6,398
+6% +$107K ﹤0.01% 1906
2022
Q4
$827K Sell
99,323
-2,219
-2% -$16.6K ﹤0.01% 2470
2022
Q3
$694K Buy
101,542
+15,875
+19% +$264K ﹤0.01% 2582
2022
Q2
$1.68M Buy
85,667
+11,858
+16% +$248K ﹤0.01% 2037
2022
Q1
$1.6M Buy
73,809
+11,952
+19% +$254K ﹤0.01% 2230
2021
Q4
$1.46M Sell
61,857
-24,941
-29% -$597K ﹤0.01% 3030
2021
Q3
$2.27M Buy
86,798
+5,191
+6% +$126K ﹤0.01% 2729
2021
Q2
$1.98M Buy
+81,607
New +$2.01M ﹤0.01% 2873

Other funds holding SHC

Credit Suisse's SHC Position: Q1 2024 in Review

Credit Suisse reduced its Sotera Health (SHC) stake by 3.4% in Q1 2024, selling an estimated $59.8K and leaving 115,425 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

Credit Suisse first reported a position in SHC in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.36M in Q2 2023. 196 funds tracked by Wall St. Rank hold SHC as of Q1 2024.

  • Credit Suisse held 115,425 shares of Sotera Health worth $1.39M as of Q1 2024.
  • Credit Suisse sold 4,018 Sotera Health shares in Q1 2024, an estimated $59.8K.
  • Sotera Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2078 holding.
  • Credit Suisse first reported a position in Sotera Health in Q2 2021 and has held it in 12 quarters since.
  • Credit Suisse's Sotera Health position peaked at $2.36M in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Sotera Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.